Search Results - Chan, L.L.
- Showing 1 - 14 results of 14
-
1
Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C by Cappellini, M.D., Elalfy, M., El-Beshlawy, A., Kattamis, A., Chan, L.L., Li, C., Lin, K.H., Quarta, G., Sutcharitchan, P., Taher, A., Habr, D., Roubert, B., Porter, J.
Published 2010Get full text
Article -
2
Insights into relationships between serum ferritin and liver iron concentration trends during 12 months of iron chelation therapy with deferasirox - a post-hoc analysis from the ep... by Porter, J.B., Elalfy, M., Taher, A.T., Chan, L.L., Lee, S.H., Sutcharitchan, P., Aydinok, Y., Chakravarty, S., El-Ali, A., El-Beshlawy, A.
Published 2014Get full text
Article -
3
Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years by Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010Get full text
Article -
4
Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial sider... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010Get full text
Article -
5
Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone t... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010Get full text
Article -
6
-
7
-
8
-
9
-
10
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia by Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010Get full text
Article -
11
-
12
-
13
Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias by Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B., Kattamis, A., Investigators, EPIC Study
Published 2010Get full text
Article -
14
Taxonomy and toxicity of Prorocentrum from Perhentian Islands (Malaysia), with a description of a non-toxigenic species Prorocentrum malayense sp. nov. (Dinophyceae) by Lim, Z.F., Luo, Z., Lee, L.K., Hii, K.S., Teng, Sing Tung, Chan, L.L., Chomérat, N., Krock, B., Gu, H., Lim, P.T., Leaw, C.P.
Published 2019Get full text
Get full text
Get full text
Article
